Keyphrases
Expert Panel
100%
Consensus Statement
100%
Patient Selection
100%
Patient Management
100%
Pulmonary Arterial Hypertension
100%
Delphi Consensus
100%
Oral Treprostinil
100%
Treprostinil
100%
Inhaled Treprostinil
100%
Consensus Recommendations
60%
Tolerability
40%
Expert Consensus
40%
Successful Transition
40%
Low Risk
20%
Published Data
20%
Titration
20%
Reassurance
20%
Hypertension Management
20%
Delphi Method
20%
Prostaglandin Analogs
20%
Lack of Response
20%
Modified Delphi Method
20%
Treatment Modalities
20%
Likert Scale
20%
Hypertension Patients
20%
Oral Route
20%
Adverse Event Management
20%
Practice Parameters
20%
Inhaled Route
20%
Robust Strategy
20%
Transition Management
20%
Medicine and Dentistry
Patient Care
100%
Patient Selection
100%
Treprostinil
100%
Oral
100%
Pulmonary Hypertension
55%
Adverse Event
11%
Titrimetry
11%
Likert Scale
11%
Reassurance
11%
Prostacyclin Derivative
11%
Treatment Modality
11%
Pharmacology, Toxicology and Pharmaceutical Science
Treprostinil
100%
Pulmonary Hypertension
55%
Tolerability
22%
Adverse Event
11%
Prostacyclin Derivative
11%
Biochemistry, Genetics and Molecular Biology
Treprostinil
100%
Reassurance
11%
Prostacyclin
11%